Kolkata News Today

The Veterinary Vaccines Market Expected to Grow at $11.80 Billion by 2028

 Breaking News
  • No posts were found

The Veterinary Vaccines Market Expected to Grow at $11.80 Billion by 2028

November 18
02:05 2020
The Veterinary Vaccines Market Expected to Grow at $11.80 Billion by 2028

Global Veterinary Vaccines Market
As mentioned in Triton’s research report, the global veterinary vaccines market, which generated $7.18 billion in 2019, is likely to register a CAGR of 5.68% by 2028.

A recent study by Triton Market Research titled ‘Global Veterinary Vaccines Market’ entails the Global Analysis and Forecasts by Disease Type (Poultry Disease, Aquaculture Disease, Bovine Disease, Porcine Disease, Canine Disease, Other Disease Type), Technology (Live Attenuated Vaccine, Toxoid Vaccine, Recombinant Vaccine, Inactivated Vaccine, Other Technology), Vaccine Type (Livestock Vaccine [Aquaculture Vaccine, Poultry Vaccine, Porcine Vaccine, Bovine Vaccine, Other Livestock Vaccine], Companion Vaccine [Canine Vaccine, Equine Vaccine, Feline Vaccine]), and by Geography (Asia-Pacific, North America, Latin America, Middle East and Africa, Europe). 

Veterinary vaccines are eco-friendly products that assist in reducing the use of antibiotics and the threat of drug-resistant microorganisms. These vaccines are vital for enhancing the welfare of the animals, reducing their proneness to diseases. This, in turn, prevents their owners from incurring financial loss in such cases. 

 

Request Free Sample of the Global Veterinary Vaccines Market Report @ https://www.tritonmarketresearch.com/reports/veterinary-vaccines-market#request-free-sample

 

Triton’s report infers that the global veterinary vaccines market is estimated to display a CAGR of 5.68% during the projected years of 2019-2028. It is further expected to generate a revenue value of $11.80 billion by 2028.

The upsurge in the occurrence of zoonotic diseases, paired with an increase in livestock diseases, drives the veterinary vaccines market’s progress. For instance, zoonotic diseases are naturally transmitted from animals to human beings owing to several factors, including consumption or direct contact with infected animals. Zoonotic tuberculosis and rabies are some of the diseases that are rapidly increasing. In such a scenario, there is an immediate need for vaccinating these animals to curb the spread of such conditions. This further augments the veterinary vaccines market growth worldwide. However, the unavailability of skilled farmers and adverse effects faced by animals post-vaccination are hindering the veterinary vaccines market development.

The global veterinary vaccines market is segmented into disease type, technology, and vaccine type. Based on disease type,  it is divided into poultry disease, aquaculture disease, bovine disease, porcine disease, canine disease, and other disease types. As per technology, it is categorized into live attenuated vaccine, toxoid vaccine, recombinant vaccine, inactivated vaccine, and other technology. At the same time, vaccine type is bifurcated into livestock and companion vaccines. The livestock is branched into aquaculture vaccine, poultry vaccine, porcine vaccine, bovine vaccine, and other livestock vaccines. Similarly, the companion vaccine is further sectioned into canine vaccine, equine vaccine, and feline vaccine.

The North American region holds the largest share in the global veterinary vaccines market, and is expected to continue its hold till 2028. The region is observing multiple advancements in the production of vaccine technology, specifically the rabies vaccine. Moreover, the research relating to applicable antigen production is also witnessed, by linking fermentation technology and continuous cell lines as substrate. In the United States and Canada, dogs are immunized by immunogenic inactivated cell culture vaccines, which are accessible at a reasonable price. This is owing to the gradual advancement in vaccine technology. For instance, a new third-generation live veterinary rabies vaccine has been developed using recombinant technology, which can be processed parenterally or orally. Therefore, continual advancement in vaccine technology is amplifying the market’s progress in the region.

Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Hygieia Biological Laboratories, HIPRA, Neogen Corporation, Virbac SA, Romvac Company SA, Phibro Animal Health Corp, Elanco (Eli Lilly And Company), Anicon Labor GmbH, Hester Biosciences Limited, Vaxxinova GmbH-Germany, Merck & Co, and Zoetis are the established competitors in this market.      

 

Purchase this Report @ https://www.tritonmarketresearch.com/reports/veterinary-vaccines-market#purchase-option

 

Question & Answer: Veterinary Vaccines Market

Question 1: What major aspects are driving the growth of the veterinary vaccines market?

Answer: The upsurge in the occurrence of zoonotic diseases, paired with an increase in livestock diseases, is driving the veterinary vaccines market’s progress. For instance, zoonotic diseases are naturally transmitted from animals to human beings owing to several factors, including consumption or direct contact with infected animals. Zoonotic tuberculosis and rabies are some of the diseases that are rapidly increasing. In such a scenario, there is an immediate requirement of vaccination to curb the spread of such conditions. This further augments the veterinary vaccines market worldwide

Question 2: What aspects are hindering the veterinary vaccines market development?

Answer: The unavailability of skilled farmers and adverse effects faced by animals post-vaccination are hindering the veterinary vaccines market development.

Question 3: Which region holds the largest share of the global veterinary vaccines market?

Answer:  The North American region holds the largest market for the veterinary vaccines market, and is expected to continue its hold till 2028. The region is observing multiple advancements in the production of vaccine technology, specifically the rabies vaccine. Moreover, the research relating to applicable antigen production is also witnessed, by linking fermentation technology and continuous cell lines as substrate.

In the United States and Canada, dogs are immunized by immunogenic inactivated cell culture vaccines, which are accessible at a reasonable price. This is owing to the gradual advancement in vaccine technology. For instance, a new third-generation live veterinary rabies vaccine is developed using recombinant technology, which can be processed parenterally or orally. Therefore, continual advancement in vaccine technology is amplifying the market’s progress in the region.

Question 4: Which are the established competitors in the veterinary vaccines market?

Answer: Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Hygieia Biological Laboratories, HIPRA, Neogen Corporation, Virbac SA, Romvac Company SA, Phibro Animal Health Corp, Elanco (Eli Lilly And Company), Anicon Labor GmbH, Hester Biosciences Limited, Vaxxinova GmbH-Germany, Merck & Co, and Zoetis are the established competitors in this market.     

 

 

Related Report:

Global Animal Nutrition Market

The global animal nutrition market is anticipated to progress at a CAGR of 5.18% during the projected phase of 2019-2028, while generating $18.05 billion in terms of revenue by 2028.

Animal nutrition products contain dietary supplements that provide health benefits, and are primarily used to enhance the animal immune system, increase livestock production, and promote animal nutrition. The organic acids, enzymes, vacuum salts, carotenoids, and vitamins are some of the market’s well-known animal nutrition products. Moreover, the rising consumption and industrialization of animal-based products have augmented the animal nutrition industry’s development.

Furthermore, the high demand for animal nutrition and industrialization of livestock are major drivers contributing to the growth of the global animal nutrition market. Likewise, the rise in disposable income among the consumers and the increase in demand for meat-based products are generating multiple opportunities for the expansion of the market. The increasing adoption of pets and animal rearing is also beneficial for the market’s advancement.

However, the high price of animal nutrition ingredients and forged products are heavily restricting the studied market’s progress. The rising environmental challenges are also hampering the animal nutrition market’s development.

Media Contact
Company Name: Triton Market Research
Contact Person: Matt Dixson
Email: Send Email
Phone: +44 7441 911839
Address:196, wards wharf approach London E16 2EQ
Country: United Kingdom
Website: https://www.tritonmarketresearch.com/